Product Details

Ratio-Ipratropium UDV

Ipratropium Bromide
250 mcg/mL
Inhalation Solution
2-mL UDV Pack

DIN/PIN/NPN

02097168

Manufacturer

Ratiopharm Inc.

Formulary Listing Date

1996-12-19  

Unit Price

1.3180

Amount MOH Pays

1.3180

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

R03BB01

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02216221 Teva-Ipratropium Sterinebs 1.3180 1.3180
02097168 Ratio-Ipratropium UDV 1.3180 1.3180
02231245 PMS-Ipratropium 1.3180 1.3180
01950681 Atrovent UDV NA NA
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
Note: For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.
265 Indefinite

Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy;

266 Indefinite

Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;

267 Indefinite

Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities;

268 Indefinite

Patients who have previously used nebulizer therapy within the last 12-month period.

 

EAP Criteria

NO

Product Monograph

View Monograph